The size of the global protein a resins market was worth USD 454.42 million in 2020. This value is forecasted to be growing at a CAGR of 8.2% and worth USD 673.9 million by 2025. The market is showcasing the evident potential in the mentioned forecasting period. Increasing research on monoclonal antibodies is expected to drive sales of Protein A resins over the forecast period.
Monoclonal antibodies can be defined as an antibody produced by a single clone of cells; the antibodies can be made in large quantities in the laboratory. They can be used to carry drugs, toxins, or radioactive substances straight to cancer cells. Monoclonal antibodies have been showing promising results in managing chronic diseases such as cancers and rheumatoid arthritis.
MARKET DRIVERS:
Growing demand for biosimilars and increasing investments in the development of biosimilar products are the major factors driving the market for monoclonal antibodies. However, raising awareness about alternate methods to purify monoclonal antibodies is expected to hamper the Protein A Resins market.
Market players deliver innovative protein A resin products such as next-generation protein A resins for clinical trials, which is expected to drive demand in the pharmaceutical and biotechnology industries. On-going research in developing new techniques is also creating chances for the protein a resins market to grow.
MARKET RESTRAINTS:
Nonetheless, the limiting factors for this market are the availability of alternative purification methods such as ultrafiltration, crystallization, high-pressure folding, and capillary electrophoresis. High prices influence both affordability and protein A resin adoption rates, which impact negatively on the growth of the industry. The high cost of Protein A resin is also a significant factor hindering the development of the market.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Covered |
By Product Type, Application, End User, Matrix Type and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore, and Expedeon Ltd. |
This research report on the global protein a resins market has been segmented & sub-segmented based on the product type, application, end-user, matrix type, and region.
Protein A Resins Market - By Product Type:
Based on product type, the segment of Recombinant Protein A accounts for the largest share of the market. Recombinant protein A is produced in E. coli and functions in the same way as normal protein A resins. Nonetheless, the recombinant protein type is favored where there is less non-specific binding provided by another production origin.
Protein A Resins Market - By Application:
Among the mentioned applications, the category of Immunoprecipitation is expected to show the highest growth during the forecast period. In the research and development sector, immunoprecipitation is widely applicable. As protein A resins are used in immunoprecipitation techniques, it is predicted that their demand will go hand in hand with increasing demand for immunoprecipitation. The growing demand for therapeutic antibodies and high antibody research and development activities will also contribute to improving the growth of the segment to some extent.
Protein A Resins Market - By Matrix Type:
Based on the matrix type, The Glass or Silica based matrix segment is expected to show significant growth over the forecast period owing to improved longevity, mechanical strength, and ability to integrate high metal dopant absorption.
Protein A Resins Market - By End User:
Based on End User, Biopharmaceutical companies make extensive use of protein A resins to purify monoclonal antibodies with great alarm. The biopharmaceutical industry's development of therapeutic monoclonal antibodies is expected to rise to meet its growing demand. As monoclonal antibodies' production increases, the demand for protein A resins for large-need purification will increase. The ever increasing trend of outsourcing large-scale production to contract research organizations would also increase the clinical research laboratories' end-user segment in the market.
Protein A Resins Market - By Region:
North America is the largest market for Protein A resin accounting for a share of approximately 37% due to many investments in the development of monoclonal antibodies, followed by Europe.
Asia Pacific region is estimated to be the fastest-growing region with a healthy compound annual growth rate due to many untapped markets and growing awareness about the developments in the market.
KEY MARKET PLAYERS:
Companies leading the Global Protein A Resins Market profiled in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore, and Expedeon Ltd.
Major Players in the market enter into strategic agreements to develop raw materials required to manufacture Protein A resins.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Natural Protein A Resin
5.1.2 Recombinant Protein A Resin
5.2 By Application
5.2.1 Immunoprecipitation
5.2.2 Antibody Purification
5.3 By End Users
5.3.1 Biopharmaceutical Manufacturers
5.3.2 Clinical Research Laboratories
5.3.3 Academic Institutes
5.4 By Matrix Type
5.4.1 Glass or Silica
5.4.2 Agarose
5.4.3 Organic Polymer
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Thermo Fisher Scientific
8.3 Repligen
8.4 Tosoh Bioscience
8.5 EMD Millipore
8.6 Novasep
8.7 GenScript
8.8 Expedeon Ltd
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
